Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Vichi

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|May 29, 2020
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patientsFrancesco Saladini, Alessia Giannini, Federica Giammarino, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2020
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible From the STOPSHIV Project CohortGiuseppe Vittorio De Socio, Elena Ricci, Paolo Maggi, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohortLucia Taramasso, Patrizia Lorenzini, Antonio Di Biagio, et al.
HIV Clinical Trials|March 2, 2018
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort<sup/>Antonella d'Arminio Monforte, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Journal of the International AIDS Society|January 22, 2019
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohortAnnalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
The New Microbiologica|July 16, 2019
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV PatientsAntonio Di Biagio, Paolo Bonfanti, Giordano Madeddu, et al.
Frontiers in Medicine|February 13, 2023
Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohortLaura Ambra Nicolini, Barbara Menzaghi, Elena Ricci, et al.
BMC Public Health|May 22, 2020
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional studyGiuseppe Vittorio De Socio, Marta Pasqualini, Elena Ricci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 19, 2012
The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective studyPaolo Bonfanti, Giuseppe Vittorio De Socio, Elena Ricci, et al.
AIDS (London, England)|July 14, 2018
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infectionPaula A S Ortega, Irma Saulle, Vincenzo Mercurio, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|May 29, 2020
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patientsFrancesco Saladini, Alessia Giannini, Federica Giammarino, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 9, 2020
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible From the STOPSHIV Project CohortGiuseppe Vittorio De Socio, Elena Ricci, Paolo Maggi, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohortLucia Taramasso, Patrizia Lorenzini, Antonio Di Biagio, et al.
HIV Clinical Trials|March 2, 2018
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort<sup/>Antonella d'Arminio Monforte, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Journal of the International AIDS Society|January 22, 2019
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohortAnnalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
The New Microbiologica|July 16, 2019
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV PatientsAntonio Di Biagio, Paolo Bonfanti, Giordano Madeddu, et al.
Frontiers in Medicine|February 13, 2023
Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohortLaura Ambra Nicolini, Barbara Menzaghi, Elena Ricci, et al.
BMC Public Health|May 22, 2020
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional studyGiuseppe Vittorio De Socio, Marta Pasqualini, Elena Ricci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 19, 2012
The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: results from a prospective studyPaolo Bonfanti, Giuseppe Vittorio De Socio, Elena Ricci, et al.
AIDS (London, England)|July 14, 2018
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infectionPaula A S Ortega, Irma Saulle, Vincenzo Mercurio, et al.
Pageof 6